Malin may issue €30m in shares
Company plans to sell between 2.5 million and 3 million shares in the company at €10 each
Malin, the biotech investment fund backed by former executives of drug firm Elan, is considering issuing up to €30 million in new shares.
The company told the Irish stock exchange last Friday that in response to market demand it plans to sell between 2.5 million and 3 million shares in the company at €10 each.
Dublin-based Malin is backed by a number of high-profile investors, including the state owned Irish Strategic Investment Fund, Aviva and Kelly Martin...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Tom Maguire: Tax changes we make now could help business for years
The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures
The Daily Briefing
What’s coming up today and what you might have missed
The Daily Briefing
What’s coming up today and what you might have missed.
